India’s output of Covid-19 shots for August-December is likely to be lower than the government’s public estimate, according to internal projections shared with Reuters by two sources.
Lower-than-expected production could delay India’s plans to vaccinate all its adults this year, amid fears the country will face another surge of coronavirus infections in the winter. India’s ongoing second wave, the world’s worst since the pandemic began, has overwhelmed its health system.
The government last week publicly estimated 1.46 billion doses of its three approved shots — AstraZeneca, Sputnik V and Covaxin — would be made between August and December.